Juha Rinne
jurin@utu.fi +358 50 441 2400 |
Publications
- White Matter Hyperintensities and Cognitive Impairment in Healthy and Pathological Aging: A Quantified Brain MRI Study (2020)
- Dementia and Geriatric Cognitive Disorders
(A1 Refereed original research article in a scientific journal) - [11C]PIB PET Is Associated with the Brain Biopsy Amyloid-β Load in Subjects Examined for Normal Pressure Hydrocephalus (2019)
- Journal of Alzheimer's Disease
(A1 Refereed original research article in a scientific journal) - Alzheimerin taudin lääkehoito (2019) Lääketieteellinen farmakologia ja toksikologia Juha Rinne, Mika Scheinin
(D2 Article in a professional compilation book) - Alzheimerin tauti sairautena (2019) Lääketieteellinen farmakologia ja toksikologia Juha Rinne, Mika Scheinin
(D2 Article in a professional compilation book) - A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies (2019)
- Alzheimer's and Dementia
(A2 Refereed review article in a scientific journal ) - Application of advanced brain positron emission tomography-based molecular imaging for a biological framework in neurodegenerative proteinopathies (2019)
- Alzheimer's & dementia: diagnosis, assessment & disease monitoring
(A2 Refereed review article in a scientific journal ) - Association between Deep Gray Matter Changes and Neurocognitive Function in Mild Cognitive Impairment and Alzheimer’s Disease: A Tensor-Based Morphometric MRI Study (2019)
- Dementia and Geriatric Cognitive Disorders
(A1 Refereed original research article in a scientific journal) - Brain beta-Amyloid and Atrophy in Individuals at Increased Risk of Cognitive Decline (2019)
- American Journal of Neuroradiology
(A1 Refereed original research article in a scientific journal) - Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) (2019)
- Alzheimer's Research and Therapy
(A1 Refereed original research article in a scientific journal) - Cessation of anti-VLA-4 therapy in a focal rat model of multiple sclerosis causes an increase in neuroinflammation (2019)
- EJNMMI Research
(A1 Refereed original research article in a scientific journal)



